Not applicableUnknownNCT06362863What this trial is testingEvaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's DiseaseWho this might be right forCrohn's Disease Ping An 52
Testing effectiveness (Phase 2)Study completedNCT00446433What this trial is testingEvaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's DiseaseWho this might be right forCrohn's Disease Celgene Corporation 90
Not applicableStudy completedNCT02851134What this trial is testingSearch for New Genetic Mutations Major Effect in Crohn's DiseaseWho this might be right forCrohn Disease University Hospital, Lille 20
Large-scale testing (Phase 3)Study completedNCT00409682What this trial is testingEfficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Abbott 192
Large-scale testing (Phase 3)Ended earlyNCT03559517What this trial is testingEfficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)Who this might be right forCrohn's Disease Shire 30
Not applicableNot Yet RecruitingNCT07663201What this trial is testingCardiovascular Risk in Patients With IBDWho this might be right forUlcerative Colitis (UC)Crohn's DiseasesCardiovascular Risk IRCCS Policlinico S. Donato 300
Early research (Phase 1)Ended earlyNCT00278577What this trial is testingHematopoietic Stem Cell Support in Patients With Severe Crohn's DiseaseWho this might be right forCROHN'S DISEASE Richard Burt, MD 25
Testing effectiveness (Phase 2)Study completedNCT01809275What this trial is testingSafety and Treatment Effect of QBECO in Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's DiseaseInflammatory Bowel Disease Qu Biologics Inc. 68
Testing effectiveness (Phase 2)Ended earlyNCT00329537What this trial is testingStudy of Sargramostim in Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Genzyme, a Sanofi Company 11
Large-scale testing (Phase 3)Study completedNCT01580670What this trial is testingClinical Study of TA-650 in Pediatric Patients With Crohn's DiseaseWho this might be right forPediatric Crohn's Disease Tanabe Pharma Corporation 14
Testing effectiveness (Phase 2)Study completedNCT00739986What this trial is testingSemapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus PlaceboWho this might be right forCrohn's Disease Ferring Pharmaceuticals 152
Large-scale testing (Phase 3)Ended earlyNCT00349752What this trial is testingCorticosteroid Sparing Effect of Certolizumab in Crohn's DiseaseWho this might be right forCrohn's Disease UCB Pharma 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT06637631What this trial is testingInvestigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.Who this might be right forCrohn's Disease Sanofi 260
Testing effectiveness (Phase 2)Looking for participantsNCT00692939What this trial is testingAutologous Stem Cell Transplantation for Crohn's DiseaseWho this might be right forCrohn's Disease Paul Szabolcs 20
Testing effectiveness (Phase 2)Study completedNCT00072943What this trial is testingA Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's DiseaseColitisIntestinal Disease+2 more Facet Biotech 175
Testing effectiveness (Phase 2)Study completedNCT00138840What this trial is testingStudy of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Synta Pharmaceuticals Corp. 282
Testing effectiveness (Phase 2)Study completedNCT01576471What this trial is testingEfficacy and Safety of Trichuris Suis Ova (TSO) as Compared to PlaceboWho this might be right forCrohn's Disease Coronado Biosciences, Inc. 250
Testing effectiveness (Phase 2)Ended earlyNCT03635112What this trial is testingEfficacy and Safety of TD-1473 in Crohn's DiseaseWho this might be right forCrohn's Disease Theravance Biopharma 167
Testing effectiveness (Phase 2)Ended earlyNCT00038766What this trial is testingCNI-1493 for Treatment of Moderate to Severe Crohn's DiseaseWho this might be right forCrohn Disease Ferring Pharmaceuticals 33
Testing effectiveness (Phase 2)Study completedNCT02513459What this trial is testingA Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease AbbVie 65